Evidence map›Paper›PMID 36031436›Full record

ArticleTherapie

An atypical Ramsey Hunt syndrome after covid 19 immunization.

Ghozlane Lakhoua, Ons Charfi, Sana Dabbeche, Ahmed Zaiem, Sarrah Kastalli, Riadh Daghfous, Sihem El Aidli

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapie. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ghozlane LakhouaCentre national de pharmacovigilance, 1006 Tunis, Tunisia; Université Tunis El Manar, faculté de médecine, unité de recherche: UR17ES12, La Rabta, 1007 Tunis, Tunisia.
Ons CharfiCentre national de pharmacovigilance, 1006 Tunis, Tunisia; Université Tunis El Manar, faculté de médecine, unité de recherche: UR17ES12, La Rabta, 1007 Tunis, Tunisia. Electronic address: ons.charfi@gmail.com.
Sana DabbecheCentre national de pharmacovigilance, 1006 Tunis, Tunisia; Université Tunis El Manar, faculté de médecine, unité de recherche: UR17ES12, La Rabta, 1007 Tunis, Tunisia.
Ahmed ZaiemCentre national de pharmacovigilance, 1006 Tunis, Tunisia; Université Tunis El Manar, faculté de médecine, unité de recherche: UR17ES12, La Rabta, 1007 Tunis, Tunisia.
Sarrah KastalliCentre national de pharmacovigilance, 1006 Tunis, Tunisia; Université Tunis El Manar, faculté de médecine, unité de recherche: UR17ES12, La Rabta, 1007 Tunis, Tunisia.
Riadh DaghfousCentre national de pharmacovigilance, 1006 Tunis, Tunisia; Université Tunis El Manar, faculté de médecine, unité de recherche: UR17ES12, La Rabta, 1007 Tunis, Tunisia.
Sihem El AidliCentre national de pharmacovigilance, 1006 Tunis, Tunisia; Université Tunis El Manar, faculté de médecine, unité de recherche: UR17ES12, La Rabta, 1007 Tunis, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adverse drug reactionCOVID 19 vaccineHerpes zosterPharmacovigilance

Identifiers

PMID36031436
PMCPMC9310341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.